Evidence map›Paper›PMID 30926273›Full record

ArticleThe American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry2019

Extent and Predictors of Potentially Inappropriate Antidepressant Use Among Older Adults With Dementia and Major Depressive Disorder.

Sandipan Bhattacharjee, Jeannie K Lee, Asad E Patanwala, Nina Vadiei, Daniel C Malone, Shannon M Knapp, Wei-Hsuan Lo-Ciganic, William J Burke

Abstract read
In one paragraph

Article in The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Evaluation of psychotropic medications use among elderly with psychiatric disorders in Saudi Arabia.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2021
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Sandipan BhattacharjeeDepartment of Pharmacy Practice and Science (SB, JKL, NV, DCM), College of Pharmacy, University of Arizona, Tucson, AZ. Electronic address: bhattacharjee@pharmacy.arizona.edu.
Jeannie K LeeDepartment of Pharmacy Practice and Science (SB, JKL, NV, DCM), College of Pharmacy, University of Arizona, Tucson, AZ.
Asad E PatanwalaUniversity of Sydney School of Pharmacy (AEP), Royal Prince Alfred Hospital, Faculty of Medicine and Health, University of Sydney, NSW, Australia.
Nina VadieiDepartment of Pharmacy Practice and Science (SB, JKL, NV, DCM), College of Pharmacy, University of Arizona, Tucson, AZ.
Daniel C MaloneDepartment of Pharmacy Practice and Science (SB, JKL, NV, DCM), College of Pharmacy, University of Arizona, Tucson, AZ.
Shannon M KnappStatistics Consulting Laboratory (SMK), Bio5 Institute, University of Arizona, Tucson, AZ.
Wei-Hsuan Lo-CiganicDepartment of Pharmaceutical Outcomes & Policy (WHLC), College of Pharmacy, University of Florida, Gainesville, FL.
William J BurkeBanner Alzheimer's Institute (WJB), Phoenix; University of Arizona College of Medicine (WJB), Phoenix; Arizona Alzheimer's Consortium (WJB), Phoenix.

Funding

Depression Treatment and Outcomes among Older Adults with Dementia in the United StatesR03MH114503 · NIMH · UNIVERSITY OF ARIZONA · PI BHATTACHARJEE, SANDIPAN · 2017 to 2018
$154k
NIMH NIH HHS R03 MH114503
6 · The paper itself

Abstract

objectiveTo quantify the extent and identify predictors of potentially inappropriate antidepressant use among older adults with dementia and newly diagnosed major depressive disorders (MDD).

methodsThis retrospective cohort study included older adults (aged ≥65 years) with dementia and newly diagnosed MDD using Medicare 5% sample claims data (2012-2013). Based on Healthcare Effectiveness Data and Information Set guidelines, intake period for new antidepressant medication use was from May 1, 2012, through April 30, 2013. Index prescription start date was the first date of antidepressant prescription claim during the intake period. Dependent variable of this study was potentially inappropriate antidepressant use as defined by the Beers Criteria and the Screening Tool of Older Persons' potentially inappropriate Prescriptions criteria. The authors conducted multiple logistic regression analysis to identify individual-level predictors of potentially inappropriate antidepressant use.

resultsThe authors' final study sample consisted of 7,625 older adults with dementia and newly diagnosed MDD, among which 7.59% (N = 579) initiated treatment with a potentially inappropriate antidepressant. Paroxetine (N = 394) was the most commonly initiated potentially inappropriate antidepressant followed by amitriptyline (N = 104), nortriptyline (N = 35), and doxepin (N = 32). Initiation of a potentially inappropriate antidepressant was associated with age and baseline use of anxiolytic medications.

conclusionMore than 7% of older adults in the study sample initiated a potentially inappropriate antidepressant, and the authors identified a few individual-level factors significantly associated with it. Appropriately tailored interventions to address modifiable and nonmodifiable factors significantly associated with potentially inappropriate antidepressant prescribing are required to minimize risks in this vulnerable population.

Indexed as

Potentially Inappropriate Medication ListAgedAged, 80 and overAntidepressive AgentsDementiaFemaleHumansInappropriate PrescribingMajor Depressive DisorderMaleMedicareRetrospective StudiesUnited StatesAntidepressive AgentsantidepressantsBeers CriteriaDementiadepressionpsychotherapyScreening Tool of Older Persons’ potentially inappropriate Prescriptions criteria

Identifiers

PMID30926273
PMCPMC6646083

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.